Literature DB >> 15635702

Pleiotropic effect of the TPH A779C polymorphism on nicotine dependence and personality.

M Reuter1, J Hennig.   

Abstract

Recent studies from molecular genetics have suggested an association between the tryptophan hydroxylase 1 (TPH1) gene and nicotine addiction indicating a dysfunction of the serotonergic (5-HT) system in smoking behavior. In a sample of 252 healthy subjects, a significant association between variations observed in nicotine dependence and the heterozygous AC-genotype of the TPH A779C polymorphism could be demonstrated. Moreover, the heterozygous genotype was significantly associated with a personality trait of neurotic aggression (indirect hostility, negativism), as measured by the Buss-Durkee-Hostility-Inventory (BDHI). The positive heterosis effects with respect to nicotine addiction and personality support the idea that the TPH1 gene exerts pleiotropic effects. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15635702     DOI: 10.1002/ajmg.b.30153

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  9 in total

1.  Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

Authors:  Sean P David; Elaine C Johnstone; Michael F G Murphy; Paul Aveyard; Boliang Guo; Caryn Lerman; Marcus R Munafò
Journal:  Drug Alcohol Depend       Date:  2008-06-17       Impact factor: 4.492

2.  Hypothesizing Music Intervention Enhances Brain Functional Connectivity Involving Dopaminergic Recruitment: Common Neuro-correlates to Abusable Drugs.

Authors:  Kenneth Blum; Thomas Simpatico; Marcelo Febo; Chris Rodriquez; Kristina Dushaj; Mona Li; Eric R Braverman; Zsolt Demetrovics; Marlene Oscar-Berman; Rajendra D Badgaiyan
Journal:  Mol Neurobiol       Date:  2016-05-31       Impact factor: 5.590

3.  Interaction between tryptophan hydroxylase I polymorphisms and childhood abuse is associated with increased risk for borderline personality disorder in adulthood.

Authors:  Scott T Wilson; Barbara Stanley; David A Brent; Maria A Oquendo; Yung-yu Huang; Fatemeh Haghighi; Colin A Hodgkinson; J John Mann
Journal:  Psychiatr Genet       Date:  2012-02       Impact factor: 2.458

4.  Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation.

Authors:  Ju Wang; Ming D Li
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

5.  The tryptophan hydroxylase-1 A218C polymorphism is associated with diagnosis, but not suicidal behavior, in borderline personality disorder.

Authors:  Scott T Wilson; Barbara Stanley; David A Brent; Maria A Oquendo; Yung-yu Huang; J John Mann
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-03-05       Impact factor: 3.568

Review 6.  Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review.

Authors:  Amy L Gillespie; Ruta Samanaite; Jonathan Mill; Alice Egerton; James H MacCabe
Journal:  BMC Psychiatry       Date:  2017-01-13       Impact factor: 3.630

7.  Impacts of GRIN3A, GRM6 and TPH2 genetic polymorphisms on quality of life in methadone maintenance therapy population.

Authors:  Ruey-Yun Wang; Hsiu-Ju Chen; Chieh-Liang Huang; Jiun-Yi Wang; Tsui-Er Lee; Hsiang-Yen Lee; Chin-Chuan Hung
Journal:  PLoS One       Date:  2018-07-30       Impact factor: 3.240

8.  Musical aptitude is associated with AVPR1A-haplotypes.

Authors:  Liisa T Ukkola; Päivi Onkamo; Pirre Raijas; Kai Karma; Irma Järvelä
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

9.  Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach.

Authors:  Sami Anttila; Olli Kampman; Ari Illi; Riikka Rontu; Terho Lehtimäki; Esa Leinonen
Journal:  BMC Psychiatry       Date:  2007-05-23       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.